HEALTHYWAY INC (02587) Achieved Record High Revenue and Profits in 2025, AI Empowers to Build the Core Growth Engine of Enterprise Services.

On the evening of March 30, HEALTHYWAY INC (02587) released the annual performance announcement for 2025. The announcement showed that HEALTHYWAY INC achieved operating revenue of 1.563 billion RMB in 2025, a year-on-year increase of 30.13%; net profit was 54.338 million RMB, turning losses into profits. At the same time, core operational data for health quality saw overall growth, with AI business commercialization beginning to show results, and enterprise services and digital marketing services becoming the core engines of performance growth. The overall business structure continued to optimize, pushing the quality of development to a new level. Steady revenue growth and significant optimization of business structure In 2025, HEALTHYWAY INC continued its trend of high-quality development, achieving a breakthrough in operational performance. Financial data showed that in addition to hitting historical highs in operating revenue and profit, gross profit increased from 366 million RMB to 476 million RMB, affirming the stability of profitability and cost control capabilities. Looking at the business structure, HEALTHYWAY INC's two core business segments demonstrated a pattern of "one core leading, co-development". Enterprise services and digital marketing services became the absolute growth engine, reaching revenue of 1.356 billion RMB in 2025, a 42.56% increase from the same period last year, with revenue share rising from 79.2% to 86.8%, becoming the core pillar supporting HEALTHYWAY INC's performance; the Health and Medical Services segment completed a strategic optimization, focusing resources on high-margin, high-growth areas. As performance began to trend positively, the market size remained in a blue ocean state. According to industry research data, the market size of China Meheco Group's digital marketing industry is expected to further grow to 91.24 billion RMB in 2025, an increase of about 18.7% year-on-year. The 42.56% growth rate of HEALTHYWAY INC's enterprise services and digital marketing services significantly exceeded the industry average, showcasing HEALTHYWAY INC's competitive advantage in the segmented field. Commercial application of AI technology, laying the foundation for new growth spaces in digitalization Building on the optimization of the business structure, HEALTHYWAY INC's digitalization strategy has entered the implementation phase. As the core layout of the digitalization strategy, HEALTHYWAY INC initiated the AI digital employee program in 2023 and fully implemented it in 2025. The first products, AI Doctor Assistant and AI Health Manager, were officially launched, and were successfully recognized as typical cases of artificial intelligence in Fujian Province in 2025, with the technology and application value gaining industry recognition. By 2025, AI Doctor Assistant and AI Health Manager had fully provided services to users on the HEALTHYWAY INC platform. The AI Doctor Assistant integrates deep language models, medical knowledge databases, and standardized diagnostic process engines to create a "dual knowledge base" system for doctors and patients. This has automated processes such as intelligent pre-diagnosis, automatic generation of medical records, and post-diagnosis follow-up reminders. It has been implemented in over 20 medical institutions nationwide, effectively enhancing the boundaries and efficiency of traditional medical services. Of note is the company's launch of customizable AI digital employees for enterprise users, generating revenue exceeding 32 million RMB in the first year of listing, becoming a new revenue growth point for HEALTHYWAY INC. From the evolution of the business path, this progress marks the completion of HEALTHYWAY INC's AI technology from product development to commercial application, and the successful operation of the B-end payment model provides new growth variables for the enterprise services segment. Continued deepening of enterprise service ecology, multiple breakthroughs in core businesses The commercial breakthrough of AI technology, alongside the expansion of the enterprise services segment, formed a synergistic relationship. In 2025, HEALTHYWAY INC's enterprise services and digital marketing services segment made breakthroughs in content services, information technology services, and other areas, achieving high-speed growth in customer scale, service capabilities, and business revenue. Indeed, content services became the vanguard of growth for the enterprise services segment. In 2025, revenue reached 888 million RMB, a 53.9% increase year-on-year, accounting for 56.8% of total revenue. Breakthrough growth was achieved in various sub-sectors, with science popularization content services achieving 960 million page views; precise content services serving 63 customers; and Real-World Evidence (RWS) covering 81 pharmaceutical companies and 11 other entities, delivering 911 reports throughout the year, providing core data support for pharmaceutical companies in drug research and insurance access. It seems that Real-World Evidence (RWS) is entering a policy dividend period. According to the strategic planning of "Real-World Evidence Supporting Scientific and Refined Management of Medical Insurance" in China, the use of RWS in medical insurance decision-making is experiencing profound changes, with 2025 being a stage of consolidating the foundation, and 2026-2027 entering the application promotion period. Against the backdrop of the continuous growth of multi-dimensional, high-value clinical data needs in the industry, the growth space for HEALTHYWAY INC's RWS business is worth paying attention to. In addition, information technology services and digital marketing services saw steady growth. In 2025, HEALTHYWAY INC provided information technology services to 455 corporate and institutional clients, generating revenue of 387 million RMB, a 30.6% increase year-on-year; original marketing articles and brand advertisements released by digital marketing services reached 1,390 articles throughout the year, a 72.7% increase year-on-year, serving 92 advertisers, continuously providing precise commercial reach solutions for pharmaceutical companies. With traditional marketing budgets of pharmaceutical companies accelerating towards precise and compliant digital channels, this industry trend provides external support for the expansion of HEALTHYWAY INC's business. Continuous expansion of platform ecology, continuous solidification of offline resource barriers The core competitiveness of digital health and medical services lies in the deep accumulation of offline medical resources and the continuous expansion of the online platform ecology. In 2025, HEALTHYWAY INC's platform ecology saw steady growth, with the connection capacity of offline medical resources continuously improving, laying a solid foundation for the company's business development. By the end of 2025, HEALTHYWAY INC had over 223 million registered personal users, over 934,000 registered doctors, and connections with 12,870 hospitals, all achieving significant growth from the previous year, continuously perfecting a nationwide medical resource network. The large user base and resources of doctors and hospitals not only laid a solid traffic foundation for HEALTHYWAY INC's health and medical services but also became a core barrier for the enterprise services segment to obtain real-world clinical data for pharmaceutical companies, realizing a mutual empowerment of "online traffic + offline resources". Looking ahead, HEALTHYWAY INC will continue to focus on the construction of the enterprise service ecology, relying on a large network of doctors and real-world clinical data, leveraging established ecological barriers, leading AI digital applications, and continuously optimized cost control capabilities, deepening strategic cooperation with pharmaceutical companies to achieve breakthrough growth in the enterprise services segment. At the same time, the company will continue to increase resources invested in the AI digital employee program, enrich the AI product matrix, drive the deep application of AI technology in medical scenarios, and open up new growth opportunities through technological empowerment.